Thomas Dimatteo
Psychiatry · Lisle, ILNPI 1487601985
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 374 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Corium, LLC$710
- Harmony Biosciences LLC$563
- Takeda Pharmaceuticals U.S.A., Inc.$504
- Tris Pharma Inc$412
- Lundbeck LLC$406
- plus $3K from 26 others
What the payments were for
- Food & beverage$6,503100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 78 | $1,201 |
| Corium, LLC | 43 | $710 |
| Harmony Biosciences LLC | 28 | $563 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $504 |
| Tris Pharma Inc | 28 | $412 |
| Lundbeck LLC | 26 | $406 |
| Otsuka America Pharmaceutical, Inc. | 16 | $312 |
| Almatica Pharma LLC | 12 | $283 |
| Ironshore Pharmaceuticals Inc. | 11 | $242 |
| Neos Therapeutics, LP | 13 | $237 |
| Vanda Pharmaceuticals Inc. | 9 | $220 |
| Bausch Health US, LLC | 9 | $163 |
| Supernus Pharmaceuticals, Inc. | 8 | $158 |
| Collegium Pharmaceutical, Inc. | 15 | $142 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $137 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| Johnson & Johnson | 5 | $110 |
| Neurocrine Biosciences, Inc. | 4 | $101 |
| Alfasigma USA, Inc. | 6 | $90 |
| OWP Pharmaceuticals, Inc. | 6 | $78 |
| Sunovion Pharmaceuticals Inc. | 3 | $54 |
| Avanir Pharmaceuticals, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Neuronetics, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Alkermes, Inc. | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
| Shire North American Group Inc | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Rhodes Pharmaceuticals L.p. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $15 |
How this compares
$6,503 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 14 | $25,085 |
| NuedextaDextromethorphan Hbr/Quinidine | 12 | $17,598 |
| Levocarnitine | 13 | $3,403 |
| Clozapine | 48 | $2,621 |
| Fluoxetine Hcl | 143 | $2,306 |
| Propranolol Hcl | 61 | $2,272 |
| Adderall XrDextroamphetamine/Amphetamine | 11 | $2,189 |
| Divalproex Sodium | 45 | $2,066 |
| Paliperidone ErPaliperidone | 13 | $1,927 |
| Quetiapine Fumarate | 22 | $1,708 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 18 | $1,500 |
| Risperidone | 71 | $1,394 |
| Atomoxetine Hcl | 13 | $1,211 |
| Aripiprazole | 38 | $1,156 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $1,070 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,201 | $25,08514 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $38 | $17,59812 claims |
| Almatica Pharma LLCSertraline Hcl | $283 | $68789 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Lisle
- Michael FeldNorthbrook$1.1M
- Jose MontesRockford$882K
- Mitchell GlaserChicago$752K
- Roukan JazayerliOrland Park$597K
- Ming XuBourbonnais$505K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Mark ShukhmanSkokie$250K
- Abid NazeerOak Brook$228K
- Nitin ThaparOrland Park$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.